This preclinical study demonstrated that IA is beneficial for COPD treatment, likely by increasing the anti-oxidative capacity and inhibiting Smad2/3 activation in lung tissue.
Li et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: